St. Jude Medical (NYSE: STJ) reported Q2 EPS of $1.06, in-line with the analyst estimate of $1.06. Revenue for the quarter came in at $1.56 billion versus the consensus estimate of $1.55 billion.

Third Quarter and Full-Year 2016 Sales and Earnings Guidance

Due to the planned merger with Abbott, St. Jude Medical is withdrawing financial guidance for the fiscal year 2016.

For earnings history and earnings-related data on St. Jude Medical (STJ) click here.